NEOGENOMICS INC — Director's Dealing 2016

May 4, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2016-04-20

Reporting Person: ROSS STEVEN A (CIO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-04-29	Common Stock	M	112500	$3.93	Acquired	117000	Direct
2016-04-29	Common Stock	S	112500	$8.11	Disposed	4500	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-04-29	Stock Option (Right to buy)	$3.93	X	112500	Disposed	2018-04-22	Common Stock (112500)	Direct
2016-04-20	Stock Option (Right to Buy)	$7.15	A	40000	Acquired	2021-04-20	Common Stock (40000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to buy)	$4.78	2020-05-06	Common Stock (100000)	100000	Direct

Footnotes

F1: On April 22, 2013, Mr. Ross was granted 150,000 stock options to purchase common stock of the Company. These options vest ratably on each of the next 4 anniversary dates of the grant date.

F2: On May 6, 2015, Mr. Ross was granted 100,000 stock options to purchase common stock of the Company. These options vest ratably on each of the first three anniversary dates of the grant date.

F3: On April 20, 2016, Mr. Ross was granted 40,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.